Nuveen LLC acquired a new stake in Herbalife Ltd (NYSE:HLF - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 292,751 shares of the company's stock, valued at approximately $2,526,000. Nuveen LLC owned approximately 0.29% of Herbalife at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in HLF. Vanguard Group Inc. grew its position in Herbalife by 10.9% in the first quarter. Vanguard Group Inc. now owns 12,495,374 shares of the company's stock valued at $107,835,000 after purchasing an additional 1,223,957 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Herbalife by 13.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,057,219 shares of the company's stock worth $26,384,000 after buying an additional 360,659 shares during the last quarter. Iridian Asset Management LLC CT lifted its stake in shares of Herbalife by 10.7% during the 1st quarter. Iridian Asset Management LLC CT now owns 2,775,430 shares of the company's stock worth $23,952,000 after buying an additional 267,690 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in shares of Herbalife by 67.0% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 2,570,226 shares of the company's stock worth $17,195,000 after buying an additional 1,031,078 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in shares of Herbalife by 14.5% during the 4th quarter. Northern Trust Corp now owns 1,002,676 shares of the company's stock worth $6,708,000 after buying an additional 126,902 shares during the last quarter.
Analysts Set New Price Targets
A number of research firms have recently issued reports on HLF. Mizuho raised their target price on shares of Herbalife from $8.00 to $9.00 and gave the stock a "neutral" rating in a research note on Monday, July 28th. Wall Street Zen cut shares of Herbalife from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 10th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $11.50.
Read Our Latest Research Report on Herbalife
Herbalife Price Performance
Herbalife stock traded up $0.06 during midday trading on Thursday, hitting $9.99. The company's stock had a trading volume of 294,573 shares, compared to its average volume of 2,141,767. Herbalife Ltd has a 1-year low of $5.04 and a 1-year high of $10.83. The company has a 50-day moving average price of $9.47 and a two-hundred day moving average price of $8.25. The company has a market cap of $1.03 billion, a price-to-earnings ratio of 3.16, a PEG ratio of 0.30 and a beta of 0.89.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.06. Herbalife had a net margin of 6.59% and a negative return on equity of 27.36%. The business had revenue of $1.26 billion during the quarter, compared to analysts' expectations of $1.27 billion. During the same quarter in the previous year, the company earned $0.54 EPS. The business's revenue was down 1.7% on a year-over-year basis. Sell-side analysts forecast that Herbalife Ltd will post 1.57 EPS for the current year.
Herbalife Company Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Articles

Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.